These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 8516592)
1. Sequential monitoring of clinical trials: the role of information and Brownian motion. Lan KK; Zucker DM Stat Med; 1993 Apr; 12(8):753-65. PubMed ID: 8516592 [TBL] [Abstract][Full Text] [Related]
2. Estimation of hurst exponent for sequential monitoring of clinical trials with covariate adaptive randomization. Yang Y; Zhu H; Lai D Contemp Clin Trials; 2022 Sep; 120():106887. PubMed ID: 35988662 [TBL] [Abstract][Full Text] [Related]
4. Use of spending functions for occasional or continuous monitoring of data in clinical trials. Lan KK; Rosenberger WF; Lachin JM Stat Med; 1993 Dec; 12(23):2219-31. PubMed ID: 8310191 [TBL] [Abstract][Full Text] [Related]
5. Practical aspects in data monitoring: a brief review. Demets DL Stat Med; 1987; 6(7):753-60. PubMed ID: 3321314 [TBL] [Abstract][Full Text] [Related]
6. Randomization as a basis for inference in noninferiority trials. Wiens BL Pharm Stat; 2006; 5(4):265-71. PubMed ID: 17128425 [TBL] [Abstract][Full Text] [Related]
7. A note on P-values under group sequential testing and nonproportional hazards. Gillen DL; Emerson SS Biometrics; 2005 Jun; 61(2):546-51. PubMed ID: 16011703 [TBL] [Abstract][Full Text] [Related]
8. Modeling and prediction of subject accrual and event times in clinical trials: a systematic review. Zhang X; Long Q Clin Trials; 2012 Dec; 9(6):681-8. PubMed ID: 22674642 [TBL] [Abstract][Full Text] [Related]
9. Sequential methods for comparing years of life saved in the two-sample censored data problem. Murray S; Tsiatis AA Biometrics; 1999 Dec; 55(4):1085-92. PubMed ID: 11315052 [TBL] [Abstract][Full Text] [Related]
10. A general formulation for a one-sided group sequential design. Moser BK; George SL Clin Trials; 2005; 2(6):519-28. PubMed ID: 16422312 [TBL] [Abstract][Full Text] [Related]
11. Brownian motion, fluctuation and life. Yanagida T; Ueda M; Murata T; Esaki S; Ishii Y Biosystems; 2007 Apr; 88(3):228-42. PubMed ID: 17187927 [TBL] [Abstract][Full Text] [Related]
12. Sequential monitoring of clinical trials with multiple survival endpoints. Williams PL Stat Med; 1996 Nov 15-30; 15(21-22):2341-57; discussion 2367-70. PubMed ID: 8931205 [TBL] [Abstract][Full Text] [Related]
13. The what, why and how of Bayesian clinical trials monitoring. Freedman LS; Spiegelhalter DJ; Parmar MK Stat Med; 1994 Jul 15-30; 13(13-14):1371-83; discussion 1385-9. PubMed ID: 7973217 [TBL] [Abstract][Full Text] [Related]
14. A unified method for monitoring and analysing controlled trials. Grossman J; Parmar MK; Spiegelhalter DJ; Freedman LS Stat Med; 1994 Sep; 13(18):1815-26. PubMed ID: 7997715 [TBL] [Abstract][Full Text] [Related]
15. Interim analyses and stopping rules in cancer clinical trials. Whitehead J Br J Cancer; 1993 Dec; 68(6):1179-85. PubMed ID: 8260370 [TBL] [Abstract][Full Text] [Related]
16. Assessment of futility in clinical trials. Snapinn S; Chen MG; Jiang Q; Koutsoukos T Pharm Stat; 2006; 5(4):273-81. PubMed ID: 17128426 [TBL] [Abstract][Full Text] [Related]
17. Stochastic description of protein conformational motion. Babinec P; Babincová M Gen Physiol Biophys; 1994 Dec; 13(6):503-7. PubMed ID: 7797057 [TBL] [Abstract][Full Text] [Related]
18. A note on sequential monitoring of select-the-winner design. Lan KK; Chen F; Zhong B; Shun Z J Biopharm Stat; 2015; 25(3):408-16. PubMed ID: 25645054 [TBL] [Abstract][Full Text] [Related]